BR112014017008A2 - composição de raio x, e, método de exame por raio x - Google Patents

composição de raio x, e, método de exame por raio x

Info

Publication number
BR112014017008A2
BR112014017008A2 BR112014017008A BR112014017008A BR112014017008A2 BR 112014017008 A2 BR112014017008 A2 BR 112014017008A2 BR 112014017008 A BR112014017008 A BR 112014017008A BR 112014017008 A BR112014017008 A BR 112014017008A BR 112014017008 A2 BR112014017008 A2 BR 112014017008A2
Authority
BR
Brazil
Prior art keywords
ray
composition
relates
examination method
iodine
Prior art date
Application number
BR112014017008A
Other languages
English (en)
Other versions
BR112014017008A8 (pt
Inventor
Newton Ben
In't Veld Dirk-Jan
Langseth Karina
Thaning Mikkel
michael evans Paul
Original Assignee
Ge Healthcare As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ge Healthcare As filed Critical Ge Healthcare As
Publication of BR112014017008A2 publication Critical patent/BR112014017008A2/pt
Publication of BR112014017008A8 publication Critical patent/BR112014017008A8/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
    • A61K49/0438—Organic X-ray contrast-enhancing agent comprising an iodinated group or an iodine atom, e.g. iopamidol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B6/00—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment
    • A61B6/02—Arrangements for diagnosis sequentially in different planes; Stereoscopic radiation diagnosis
    • A61B6/03—Computed tomography [CT]
    • A61B6/032—Transmission computed tomography [CT]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B6/00—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment
    • A61B6/48—Diagnostic techniques
    • A61B6/481—Diagnostic techniques involving the use of contrast agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical & Material Sciences (AREA)
  • Optics & Photonics (AREA)
  • Physics & Mathematics (AREA)
  • Radiology & Medical Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biophysics (AREA)
  • High Energy & Nuclear Physics (AREA)
  • Surgery (AREA)
  • Molecular Biology (AREA)
  • Pathology (AREA)
  • Pulmonology (AREA)
  • Theoretical Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Apparatus For Radiation Diagnosis (AREA)
  • Medicinal Preparation (AREA)

Abstract

1 / 1 resumo “composiã‡ãƒo de raio x, e, mã‰todo de exame por raio x” a presente invenã§ã£o diz respeito a exames por raio x e ã  melhora da seguranã§a do paciente durante tal. mais especificamente, a invenã§ã£o diz respeito a composiã§ãµes de diagnã³stico por raio x tendo concentraã§ãµes baixas de iodo e uma quantidade otimizada de eletrã³litos. a invenã§ã£o ainda diz respeito a mã©todos de exames por raio x em que um corpo ã© administrado com um uma composiã§ã£o de diagnã³stico por raio x que compreende uma concentraã§ã£o baixa de iodo e irradiado com uma dose de radiaã§ã£o.
BR112014017008A 2012-01-11 2013-01-10 composição de raio x, e, método de exame por raio x BR112014017008A8 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP12150785 2012-01-11
PCT/EP2013/050342 WO2013104690A1 (en) 2012-01-11 2013-01-10 X-ray imaging contrast media with low iodine concentration and x-ray imaging process

Publications (2)

Publication Number Publication Date
BR112014017008A2 true BR112014017008A2 (pt) 2017-06-13
BR112014017008A8 BR112014017008A8 (pt) 2017-07-04

Family

ID=47522694

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112014017008A BR112014017008A8 (pt) 2012-01-11 2013-01-10 composição de raio x, e, método de exame por raio x

Country Status (15)

Country Link
US (1) US10004816B2 (pt)
EP (1) EP2802357A1 (pt)
JP (1) JP6423274B2 (pt)
KR (1) KR102020080B1 (pt)
CN (2) CN104114190A (pt)
AU (1) AU2013208955B2 (pt)
BR (1) BR112014017008A8 (pt)
CA (1) CA2862495A1 (pt)
IL (1) IL233244A (pt)
MX (1) MX2014008517A (pt)
NZ (1) NZ626988A (pt)
RU (1) RU2664418C2 (pt)
SG (1) SG11201403963XA (pt)
WO (1) WO2013104690A1 (pt)
ZA (1) ZA201405528B (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2862495A1 (en) 2012-01-11 2013-07-18 Ge Healthcare As X-ray imaging contrast media with low iodine concentration and x-ray imaging process
CN105579069A (zh) * 2013-03-27 2016-05-11 通用电气医疗集团股份有限公司 用于制备诊断组合物的方法和试剂
KR101864992B1 (ko) * 2017-03-09 2018-07-04 국립암센터 Mri 노이즈 제거용 조성물 및 이를 이용한 패드
RU2706364C1 (ru) * 2018-12-07 2019-11-18 Федеральное государственное бюджетное учреждение науки Байкальский институт природопользования Сибирского отделения Российской академии наук (БИП СО РАН) Композиция для рентгендиагностики на основе иодированной полимерной матрицы
CN113423438A (zh) * 2019-02-06 2021-09-21 威廉·E·巴特勒 用于血管造影的改进方法
KR102628083B1 (ko) 2019-02-06 2024-01-26 윌리암 이. 버틀러 복수의 저차원 혈관 조영 프로젝션들로부터 움직이는 혈관 맥파의 시공간적 재구성
EP3927237A4 (en) 2019-03-27 2022-11-23 William E. Butler RECONSTRUCTION OF HEART RATE PHENOMENA IN ANGIOGRAPHIC DATA
US11030742B2 (en) * 2019-03-29 2021-06-08 GE Precision Healthcare LLC Systems and methods to facilitate review of liver tumor cases
WO2020206430A1 (en) 2019-04-04 2020-10-08 Butler William E Intrinsic contrast optical cross-correlated wavelet angiography
CN113706538A (zh) * 2021-10-28 2021-11-26 中国医学科学院北京协和医院 确定肾细胞癌级别的系统及其应用

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0108638B1 (en) 1982-11-08 1986-07-16 NYEGAARD & CO. A/S X-ray contrast agents
US4887604A (en) * 1988-05-16 1989-12-19 Science Research Laboratory, Inc. Apparatus for performing dual energy medical imaging
GB8916781D0 (en) * 1989-07-21 1989-09-06 Nycomed As Compositions
SU1748796A1 (ru) * 1989-12-20 1992-07-23 Московский Научно-Исследовательский Рентгенорадиологический Институт Способ ретроградной илеографии
GB9419203D0 (en) * 1994-09-23 1994-11-09 Nycomed Innovation Ab Contrast media
US6333971B2 (en) * 1995-06-07 2001-12-25 George S. Allen Fiducial marker
KR20000052855A (ko) 1996-11-01 2000-08-25 죠지 에이치 밀레이 조율가능한 엑스레이 소스로서의 구형의 관성 정전 억류 장치
KR20070015517A (ko) 2004-03-11 2007-02-05 말린크로트, 인코포레이티드 요오드화된 단량체 및 이량체의 혼합물을 포함하는 ｘ-선조영제 제형
US7713517B2 (en) 2004-04-21 2010-05-11 Marval Biosciences, Inc. Compositions and methods for enhancing contrast in imaging
US8357351B2 (en) * 2004-04-21 2013-01-22 Ananth Annapragada Nano-scale contrast agents and methods of use
US20060072800A1 (en) 2004-09-24 2006-04-06 General Electric Company Method and system for distributed iterative image reconstruction
DE102005052368B4 (de) 2005-10-31 2015-07-30 Bayer Pharma Aktiengesellschaft Röntgensystem zur Erstellung diagnostischer Röntgendarstellungen unter Applikation von Kontrastmitteln
BRPI0814811A2 (pt) 2007-07-12 2015-02-03 Ge Healthcare As Composto, agente, método, e composição de diagnóstico, uso de um composto, e, método de formação de imagem
WO2009047319A1 (en) * 2007-10-12 2009-04-16 Ge Healthcare As Contrast agents
US20110256068A1 (en) 2009-01-09 2011-10-20 Wistand Lars-Goeran Contrast media compositions
JP5335147B2 (ja) * 2009-10-29 2013-11-06 ジーイー・ヘルスケア・アクスイェ・セルスカプ 優れた安全性プロファイルを有する血漿陽イオンを含む診断用組成物
KR101915821B1 (ko) 2010-03-23 2018-11-06 지이 헬스케어 에이에스 안정화된 ｘ―선 진단용 조성물의 제조
WO2012007456A1 (en) * 2010-07-12 2012-01-19 Ge Healthcare As X-ray imaging at low contrast agent concentrations and/or low dose radiation
CA2862495A1 (en) 2012-01-11 2013-07-18 Ge Healthcare As X-ray imaging contrast media with low iodine concentration and x-ray imaging process

Also Published As

Publication number Publication date
ZA201405528B (en) 2015-11-25
AU2013208955B2 (en) 2017-11-16
EP2802357A1 (en) 2014-11-19
MX2014008517A (es) 2014-08-21
RU2014125447A (ru) 2016-02-27
WO2013104690A1 (en) 2013-07-18
JP6423274B2 (ja) 2018-11-14
SG11201403963XA (en) 2014-08-28
CN107982550A (zh) 2018-05-04
CN104114190A (zh) 2014-10-22
IL233244A (en) 2017-01-31
KR102020080B1 (ko) 2019-11-04
NZ626988A (en) 2015-10-30
BR112014017008A8 (pt) 2017-07-04
RU2664418C2 (ru) 2018-08-17
JP2015504074A (ja) 2015-02-05
IL233244A0 (en) 2014-08-31
KR20140109420A (ko) 2014-09-15
AU2013208955A1 (en) 2014-07-24
CA2862495A1 (en) 2013-07-18
US20150190533A1 (en) 2015-07-09
US10004816B2 (en) 2018-06-26

Similar Documents

Publication Publication Date Title
BR112014017008A8 (pt) composição de raio x, e, método de exame por raio x
BR112012033776A2 (pt) composição,e, método de exame de raios-x.
BR112015027282A8 (pt) formulação líquida e kit compreendendo fenfluramina, e usos da mesma no tratamento de síndrome de dravet
FI20110105L (fi) Kollimaattorijärjestely intraoraaliröntgenkuvantamisen yhteydessä
BR112017028132A2 (pt) métodos de tratamento de malignidade hematológica usando terapia combinada de inibidor de mtor em nanopartícula
BR112017024777A2 (pt) uso de uma composiçao farmacêutica e de um antibiótico não absorvível para tratamento de transtorno do espectro autista referência cruzada a pedidos relacionados?
BR112012027092A2 (pt) métodos e composiões para reduzir ou impedir a calcificação vascular durante a terapia de diálise peritoneal
NI201200179A (es) Métodos de tratamiento contra el cáncer pancreático
BR112012024442A2 (pt) métodos de tratamento de câncer
BR112012031163A2 (pt) métodos de terapia combinada para tratamento de doenças proliferativas
BR112014003414A2 (pt) método de produção de níveis fisiológicos e terapêuticos de óxido nítrico através de um sistema de entrega oral
BR112015006623A2 (pt) laquinimod e pridopidina para o tratamento de doenças neurodegenerativas
BR112012024349A2 (pt) métodos de tratamento de carcinoma hepatocelular
BR112014031394A8 (pt) Composições compreendendo ciclobenzaprina ou amitriptilina e seus usos via absorção transmucosa oral
MX2013007189A (es) Metodos y composiciones adecuados para manejar glucosa en sangre en animales.
BR122019025997B8 (pt) uso de uma população de nanopartículas metálicas
BR112013005673A2 (pt) uso de lipase de ácido lisossomal para tratamento de deficiência de lipase de ácido lisossomal em pacientes
BR112017006113A8 (pt) usos de auristatina, composições farmacêuticas, formas de dosagem para o tratamento de câncer e kits.
CY1122427T1 (el) Συνθεση για την προφυλαξη απο καντιντιαση
BR112014031372A2 (pt) implantes/procedimentos relacionados ao avanço da tuberosidade tibial
BRPI0907970A8 (pt) composição para tratamento dos cabelos ou pelos e método para aumentar o diâmetro dos cabelos ou pelos
BR112013007423A2 (pt) terapia combinada no que diz respeito ao tratamento da infecção por hcv
BR112012019921A2 (pt) composições líquidas compreendendo um agente de resfriamento não-metol e um espessante para tratamento de um sintoma respiratório.
CR20110226A (es) Composición para tratar enfermedad
EA023535B9 (ru) Композиция водного радиопротекторного фармацевтического раствора и способ предотвращения, снижения или исключения эффектов ионизирующей радиации

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07G Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette]

Free format text: NOTIFICACAO DE DEVOLUCAO DO PEDIDO POR NAO SE ENQUADRAR NO ART. 229-C DA LPI.

B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B350 Update of information on the portal [chapter 15.35 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 9A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2652 DE 03-11-2021 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.